
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 962 | 1019 | 1212 | 1899 | 3013 | 3146 |
Fund Return | -3.81% | 1.92% | 21.24% | 23.84% | 24.68% | 12.14% |
Place in category | 5 | 17 | 19 | 8 | 13 | 15 |
% in Category | 4 | 27 | 19 | 9 | 21 | 72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Reg Div Payout | 725.55B | 4.48 | 12.67 | 11.78 | ||
SBI Magnum Balanced Fund Direct Div | 725.55B | 4.70 | 13.44 | 12.71 | ||
SBI Magnum Balanced Fund Direct Gro | 725.55B | 4.70 | 13.44 | 12.80 | ||
SBI Magnum Balanced Fund Regular Gr | 725.55B | 4.48 | 12.67 | 11.86 | ||
SBI Blue Chip Fund Direct Dividend | 493.94B | 1.81 | 15.29 | 13.41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 80.81B | -5.71 | 20.06 | 14.25 | ||
Reliance Pharma Dividend Payout | 80.81B | -6.49 | 19.44 | 15.20 | ||
Reliance Pharma Fund - Growth | 80.81B | -5.71 | 20.06 | 14.25 | ||
Reliance Pharma Direct Bonus | 80.81B | -5.43 | 21.15 | 15.27 | ||
Reliance Pharma Direct Growth | 80.81B | -5.43 | 21.15 | 15.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.45 | 1,743.50 | +2.09% | |
Max Healthcare Institute | INE027H01010 | 6.68 | 1,173.20 | +0.73% | |
Divi's Labs | INE361B01024 | 6.00 | 6,565.50 | +1.75% | |
Cipla | INE059A01026 | 4.79 | 1,485.90 | +2.17% | |
Lupin | INE326A01037 | 4.72 | 2,012.80 | +2.33% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review